Medically reviewed by Veronica Anderson, LMHC, LMFT, LPCC, LPC — Clinical Director, RYSE Wellness · Last reviewed June 2026
qEEG brain mapping measures your brain’s electrical activity, compares it to a normative database, and turns the result into color-coded maps that help clinicians personalize treatment. It’s a decision-support tool for care planning — not a standalone diagnosis.
This article is for adults considering or referred to residential mental health care. RYSE Wellness provides residential treatment for adults only.
Key takeaways
- What it measures: qEEG quantifies power and connectivity across five brainwave bands (delta, theta, alpha, beta, gamma) to map how regions function and communicate.
- How RYSE uses it: results guide medication strategy, TMS targeting, and therapy focus — combined with a full psychiatric evaluation, never on their own.
- Testing cadence: RYSE uses an FDA-cleared Firefly Neuro device and maps three times — intake, midway, discharge — so you can see measurable change.
- The appointment: a 20–40 minute non-invasive recording; processing and clinician review typically follow within 24–72 hours.
- Who it helps: adults with treatment-resistant patterns, often after two or more outpatient trials that didn’t hold.
- Safety and limits: painless and non-invasive, with no radiation; accuracy depends on clean data and expert interpretation.
What qEEG brain mapping is
qEEG (quantitative electroencephalography) records your brain’s electrical activity and quantifies it into statistical, color-coded maps. Those maps let clinicians compare your brain to large reference databases and spot atypical activity that can guide treatment.
It starts like a standard EEG: a technician places sensors on your scalp and records activity while you rest. Software then extracts spectral and connectivity measures and renders them as topographic maps.
At RYSE Wellness, FDA-cleared qEEG is paired with in-house TMS to personalize care for adults who haven’t responded to prior outpatient treatment. You can see the service details on the qEEG brain mapping page.
qEEG is a decision-support tool, not a diagnosis. Peer-reviewed work has linked reproducible qEEG patterns to mood and cognitive disorders, which supports its use in planning (EEG biomarkers in mood disorders, systematic review).
How qEEG works and what it measures
The recording is digitized and analyzed to quantify activity across frequency bands and connectivity measures. Those numbers are compared to normative data and rendered as maps that highlight deviations from typical patterns.
Clinicians read three main things: frequency-band power (delta through gamma), connectivity and coherence (how regions communicate), and asymmetry (where one side or band differs from norms). Each is interpreted alongside your history, not in isolation.
Table 1 — Brainwave bands and how RYSE uses them
| Band | Patient-friendly meaning | What it can signal | How RYSE may use it |
|---|---|---|---|
| Delta (0.5–4 Hz) | Deep-sleep rhythm; awake delta feels like slowed thinking | Diffuse slowing or focal dysfunction | Consider medical workup; adjust program intensity |
| Theta (4–8 Hz) | Drowsiness, inattention, mental fog | Often elevated in attention difficulties | Emphasize cognitive/attention work; inform TMS parameters |
| Alpha (8–12 Hz) | Calm, relaxed wakefulness | Frontal asymmetry can relate to mood | Time active therapy when engagement is supported |
| Beta (12–30 Hz) | Alertness; high beta can feel anxious | May reflect anxiety or medication effects | Review medications; prioritize anxiety-focused therapy |
| Gamma (>30 Hz) | Fast processing, attention, working memory | Emerging, exploratory marker | Track over time; used cautiously in decisions |
These outputs guide treatment choices such as TMS targeting and medication adjustments. They never replace clinical judgment or your preferences.
How qEEG differs from a standard EEG
Both begin with the same scalp recording, then diverge. A standard EEG reviews raw waveforms to detect events like seizures; qEEG applies statistics to map brain function over time.
Table 2 — qEEG vs. standard EEG
| Attribute | qEEG (brain mapping) | Standard EEG |
|---|---|---|
| Purpose | Quantify activity to guide and track treatment | Detect electrical abnormalities (seizures) for diagnosis |
| Analysis | Spectral, connectivity, normative comparison | Visual waveform review, event detection |
| Typical setting | Treatment planning, neuromodulation programs | ER, neurology, pre-surgical workups |
| Output | Color-coded statistical maps, z-scores | Waveform tracings, physician impression |
| Best when | You want measurable targets and progress tracking | Seizure diagnosis or acute event capture is needed |
If the question is “are these spells seizures,” a standard EEG comes first. If prior treatment hasn’t worked and you want a data-driven plan, qEEG adds value. The two often complement each other.
What to expect during a qEEG at RYSE
The setup is non-invasive — scalp sensors only, no needles or shocks. A technician measures your head, fits a sensor cap, and applies a cool conductive gel.
Most of the appointment is quiet recording of baseline activity with eyes open and closed, usually 20–40 minutes plus setup. Everyday movement can create artifacts, so a brief re-scan for cleaner data is routine, not a sign of failure.
Raw recordings then run through a processing pipeline, typically ready in 24–72 hours. A clinician reviews the maps with you in plain language and explains how the findings shape your plan.
Across a 30–45 day stay, the schedule is consistent: an intake scan within about 24 hours, a midpoint re-scan around day 14–22, and a discharge scan in the final 48 hours. Your data is stored in HIPAA-protected systems.
How clinicians at RYSE turn a map into a plan
A qEEG map is a snapshot of where your activity differs from typical patterns. At RYSE, the result feeds a multidisciplinary team — psychiatry, the Clinical Director, and therapists — who translate it into specific choices.
That might mean adjusting medication strategy, selecting TMS coil placement and frequency, or shifting therapy emphasis across CBT, DBT, and ACT. Any change to stimulation parameters is clinically reviewed and signed off before use.
Because RYSE maps three times, the team can check whether an intervention is moving brain activity in the right direction and adjust mid-course. The findings also feed a clinical, neurologically informed treatment plan built around your nervous system.
Who should consider qEEG
qEEG is most useful for adults whose prior outpatient or brief inpatient care didn’t produce lasting improvement. It adds value when combined with psychiatric evaluation, psychotherapy, and evidence-based treatment like TMS. It also complements a holistic, whole-person therapy model that addresses lifestyle, stress, and emotional health together.
Typical candidates include adults with treatment-resistant depression, complex mood disorders, PTSD or trauma, ADHD, and dual diagnosis where mental health is the primary focus. For the depression cases in that group, mapping is folded directly into our treatment-resistant depression program, where the intake map informs medication and TMS decisions rather than sitting in a separate report.
It isn’t right for everyone. Recordings can be unreliable during acute intoxication or withdrawal, scalp wounds may delay mapping, and implanted electronic devices need a case-by-case safety review.
What qEEG can and can’t do
qEEG can identify measurable patterns that guide treatment focus, inform medication and TMS decisions, and provide objective tracking across your stay. That objectivity is the point — it reduces guesswork when prior care gave only partial relief.
It cannot diagnose a psychiatric disorder by itself, replace a clinical interview, or guarantee a specific outcome. It’s one data point combined with history, symptom measures, and clinician judgment.
Accuracy also varies with data quality. Muscle movement, electrode placement, and different normative databases can all shift results, which is why expert interpretation and repeated maps matter (Arns et al. meta-analysis).
Questions worth asking any residential program
- Do you perform FDA-cleared qEEG brain mapping, and how many times during a typical stay?
- Which patterns guide your TMS and medication decisions, and can you show de-identified examples?
- How does qEEG concretely change coil placement, frequency, or dosing?
- What outcome data do you track to validate your approach?
A clear answer signals a program that treats qEEG as a clinical tool, not a marketing badge. RYSE’s combined qEEG-and-TMS approach is described on the therapies page.
Frequently asked questions
What does a qEEG brain map show?
Patterns of electrical activity across regions and frequency bands. Clinicians look for areas that are unusually over- or under-active to spot dysregulation linked to symptoms, then target treatment and track change.
How is qEEG different from EEG?
An EEG records raw brain waves in real time. qEEG takes that recording, applies algorithms, and compares it to a normative database to produce color-coded maps and metrics.
Can qEEG diagnose mental illness?
No. It can reveal atypical patterns that correlate with conditions like depression or PTSD, but clinicians combine it with history and exams before any diagnosis.
Is qEEG safe?
Yes. It’s non-invasive — sensors sit on the scalp to record activity. No radiation, no injections, no stimulation during recording. Some people notice mild discomfort from the cap or gel.
How long does it take?
The recording runs about 20–40 minutes plus setup. Processing typically takes 24–72 hours before your review meeting.
Will insurance cover it?
Coverage varies. Some PPO out-of-network plans cover qEEG as part of a treatment package. You can get a confidential, no-obligation benefits check through our insurance verification form.
Will qEEG tell me which treatment will work?
It can increase the precision of treatment selection by highlighting neural targets, but it doesn’t guarantee a specific therapy will succeed. At RYSE, findings feed clinical treatment planning alongside psychiatric evaluation and your goals.
Next steps at RYSE
At RYSE in Fallbrook, California, we treat qEEG brain mapping as an evidence-informed adjunct that sharpens clinical decisions — performed three times during your stay so progress is something you can see.
If prior treatment gave only partial relief, a data-driven next step may help. Start with a free, confidential verification of benefits or a no-obligation clinical conversation. Our admissions team can run your insurance check or talk through whether RYSE fits.
Call (760) 266-5430 for a confidential conversation, or request a clinical consultation.
This page is informational and is not a substitute for professional diagnosis. If you are in crisis, call or text 988.